Clinical Trials Directory

Trials / Completed

CompletedNCT00672100

Initial Local Anesthetic Dose With Continuous Interscalene Analgesia

The Effect Of Initial Local Anesthetic Dose With Continuous Interscalene Analgesia On Postoperative Pain And Diaphragmatic Function In Arthroscopic Shoulder Surgery Patients: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Corewell Health East · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Objective: To determine a minimally effective initial local anesthetic bolus required to provide satisfactory analgesia using continuous brachial plexus infusion following arthroscopic shoulder surgery using a double-blind, randomized, study comparing 3 initial doses.

Detailed description

Aims: 1. To compare pain ratings and supplemental analgesic requirements at discharge from PACU, 24 hours, and 48 hours and 12 weeks following 5, 10, and 20 ml boluses. 2. To compare adverse events including clinical dysphonia, Horner's syndrome, dyspnea, unexpected hospitalization, evidence of local anesthetic toxicity, and hand weakness at discharge from PACU following 5, 10, and 20 ml boluses. 3. To compare impairment in diaphragmatic excursion at discharge from PACU following 5, 10, and 20 ml boluses. 4. To compare patients' satisfaction with analgesia at 24 and 48 hours following 5, 10, and 20 ml boluses. 5. To compare patient rating of functional outcome at baseline and at 12 weeks following 5, 10, and 20 ml boluses. 6. To compare the rate of general anesthesia required following 5, 10, and 20 ml boluses.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineInitial Bolus 5 ml Ropivacaine via interscalene injection
DRUGRopivacaineInitial Bolus 10 ml Ropivacaine via interscalene injection
DRUGRopivacaineInitial Bolus 20 ml Ropivacaine via interscalene injection

Timeline

Start date
2009-01-01
Primary completion
2010-02-01
Completion
2010-08-01
First posted
2008-05-06
Last updated
2017-03-07
Results posted
2013-05-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00672100. Inclusion in this directory is not an endorsement.